论文部分内容阅读
《规划》提出的目标包括:产业规模平稳较快增长、确保基本药物供应、技术创新能力增强、质量安全上水平、产业集中度提高、国际竞争力增强、节能减排取得成效。“十二五”期间,将力争医药工业总产值年均增长20%,工业增加值年均增长16%。《规划》提出,将建立健全的以企业为主体的技术创新体系,重点骨干企业研发投入达到销售收入的5%以上,创新能力明显提
The targets set out in the Plan include steady and rapid growth of industrial scale, ensuring the supply of essential medicines, enhancing technological innovation capacity, improving quality and safety level, enhancing industrial concentration, enhancing international competitiveness and achieving energy conservation and emission reduction. During the 12th Five-Year Plan, the output value of the pharmaceutical industry will strive to achieve an average annual increase of 20% and that of industrial added value will increase by an average of 16% annually. “Planning” proposed that a sound enterprise-oriented technological innovation system will be established and key R & D investment of key enterprises will reach over 5% of sales revenue with obvious innovation capability